|
|
Volumn 48, Issue 4, 2014, Pages 548-549
|
|
Efficacy of Valganciclovir Plus Cytomegalovirus Immune Globulin for Prevention of Cytomegalovirus Disease in High-Risk Renal Transplant Recipients
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYTOMEGALOVIRUS ANTIBODY;
VALGANCICLOVIR;
ANTIVIRUS AGENT;
CYTOMEGALOVIRUS-SPECIFIC HYPERIMMUNE GLOBULIN;
GANCICLOVIR;
IMMUNOGLOBULIN;
ARTICLE;
CYTOMEGALOVIRUS INFECTION;
DRUG EFFICACY;
GOLD STANDARD;
GRAFT RECIPIENT;
HEART TRANSPLANTATION;
HUMAN;
INTESTINE GRAFT;
KIDNEY GRAFT;
LIVER TRANSPLANTATION;
LOW DRUG DOSE;
LUNG TRANSPLANTATION;
MAJOR CLINICAL STUDY;
PANCREAS TRANSPLANTATION;
PRIORITY JOURNAL;
RISK FACTOR;
VIRUS REPLICATION;
ANALOGS AND DERIVATIVES;
CYTOMEGALOVIRUS INFECTIONS;
DRUG COMBINATION;
KIDNEY TRANSPLANTATION;
RETROSPECTIVE STUDY;
ANTIVIRAL AGENTS;
CYTOMEGALOVIRUS INFECTIONS;
DRUG THERAPY, COMBINATION;
GANCICLOVIR;
HUMANS;
IMMUNOGLOBULINS;
KIDNEY TRANSPLANTATION;
RETROSPECTIVE STUDIES;
|
|
EID: 84898683033
PISSN: 10600280
EISSN: 15426270
Source Type: Journal
DOI: 10.1177/1060028013513427 Document Type: Article |
|
Times cited : (1)
|
|
References (4)
|
